Holen Sie sich die Stockscreener-App
9.1362
5.50%
0.4762
Scisparc Ltd Aktie (SPRC) Neueste Nachrichten
SciSparc Ltd. Ordinary Shares Stock Short Interest Rises to 66.94% - Moomoo
SPRC Stock Price, Quote & Chart - ChartMill
SciSparc Ltd.'s Equity Buyback announced on July 7, 2022, has expired. - marketscreener.com
Why is SciSparc stock skyrocketing on Thursday? - MSN
SciSparc more than doubles as NeuroThera wins conditional nod for CliniQuantum deal - MSN
NeuroThera completes acquisition of 54% stake in CliniQuantum - Investing.com UK
In today's session, these stocks are experiencing unusual volume. - ChartMill
Which stocks are gapping on Thursday? - ChartMill
SPRC Stock Pops As SciSparc Pushes Into Quantum Clinical Analytics - timothysykes.com
SciSparc Subsidiary NeuroThera Labs Closes Majority Acquisition of CliniQuantum - TipRanks
These stocks that are showing activity before the opening bell on Thursday. - ChartMill
NeuroThera completes acquisition of 54% stake in CliniQuantum By Investing.com - Investing.com India
SciSparc (NASDAQ: SPRC) unit NeuroThera acquires 54% of CliniQuantum in CAD$9.46M share deal - Stock Titan
Quantum trial-analysis startup CliniQuantum sold in C$9.5M SciSparc deal - Stock Titan
SciSparc Ltd. Subsidiary NeuroThera Labs Inc. Completes Acquisition of 54% Stake in CliniQuantum Ltd. - Quiver Quantitative
NeuroThera Labs Inc. Announces Closing of Acquisition of Majority Stake in CliniQuantum Ltd. - Yahoo Finance
Neurothera Labs Inc. Announces Closing Of Acquisition Of Majority Stake In Cliniquantum Ltd. - marketscreener.com
SciSparc's Quantum Gambit: Betting on AI to Remake Drug Trials - BriefGlance
Director Itschak Shrem Sells Shares of SciSparc Ltd (SPRC) - GuruFocus
SciSparc (SPRC) director Itschak Shrem sells 462 Ordinary Shares at $10 - Stock Titan
SciSparc Shares Jumped Last Week, Market Awaits Monday Deal Deadline - Bez Kabli
SciSparc Subsidiary Wins Conditional TSXV Nod for CliniQuantum Acquisition, Amends Deal Terms - TipRanks
SciSparc (Nasdaq: SPRC) unit to buy 54% of CliniQuantum in share deal - Stock Titan
SciSparc stock surges 200% on NeuroThera acquisition progress - Investing.com
Top Biotech Gainers: SPRC Deal Gets Nod, CODX Rallies, OTLK, AKTX, FTRE Drawing Investor Interest - RTTNews
SciSparc Ltd. (SPRC) Stock: Shares Soar 202% on NeuroThera’s TSX Approval - MEXC
SciSparc stock surges 157% after subsidiary gets conditional TSX approval for major acquisition - Pluang
SciSparc Ltd. (SPRC) Stock Explodes 202% Following NeuroThera’s TSX Exchange Milestone - MEXC
SciSparc Jumps 150.8% as Subsidiary Wins Conditional Exchange Approval for CliniQuantum Deal - Moomoo
SciSparc jumps 150.8% as subsidiary wins conditional exchange approval for CliniQuantum deal - Quiver Quantitative
Why Is SciSparc Stock Skyrocketing On Thursday? - Benzinga
SciSparc Ltd. (SPRC) Stock Explodes 202% Following NeuroThera's TSX Exchange Milestone - Blockonomi
SciSparc (SPRC) Stock Rockets 202% as NeuroThera Gets TSX Green Light - MoneyCheck
NeuroThera receives conditional approval for CliniQuantum deal - Investing.com UK
SciSparc stock surges 200% on NeuroThera acquisition progress By Investing.com - Investing.com India
SciSparc’s NeuroThera Labs Gets Conditional Approval to Acquire CliniQuantum - geneonline.com
Trending Stocks Today | SciSparc Shoots up 219.58% - Moomoo
SPRC Stock Explodes As Bullish Upgrades Hit Tape - StocksToTrade
SciSparc: Subsidiary NeuroThera Labs Received Conditional Regulatory Approval for Acquisition of CliniQuantum - markets.businessinsider.com
NeuroThera receives conditional approval for CliniQuantum deal By Investing.com - Investing.com Nigeria
SPRC Stock Draws Bullish Upgrades As Traders Circle - timothysykes.com
1.02%
2.34%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):